Lista de obras -

10-year follow-up of intensive glucose control in type 2 diabetes

artículo científico publicado en 2008

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.

artículo científico publicado en 2013

Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes.

artículo científico publicado en 2004

Algorithm: management of diabetes mellitus.

artículo científico publicado en 2009

Algorithm: management of diabetes mellitus: dietary and drug therapy.

artículo científico publicado en 2009

Basal insulin therapy in type 2 diabetes.

artículo científico publicado en 2005

Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

artículo científico publicado en 2017

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

artículo científico

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study

scientific article published on 26 July 2012

Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study

scientific article published on 10 July 2007

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance

artículo científico publicado en 2017

Emerging care for type 2 diabetes: using insulin to reach lower glycemic goals.

artículo científico publicado en 2005

Evaluation of a self-administered oral glucose tolerance test

artículo científico publicado en 2013

Impact of FDA guidance for developing diabetes drugs on trial design: from policy to practice.

artículo científico

Improper insulin administration may explain poor diabetes control

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research tri

artículo científico publicado en 2013

Insulin analogues: new therapies for type 2 diabetes mellitus.

artículo científico publicado en 2002

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

artículo científico publicado en 2008

Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients.

artículo científico publicado en 2007

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

artículo científico publicado en 2018

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease.

artículo científico publicado en 2017

Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.

artículo científico publicado en 1997

Oral agent therapy in the treatment of type 2 diabetes.

artículo científico publicado en 1999

Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus

artículo científico publicado en 2014

Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial

artículo científico publicado en 2015

Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.

artículo científico publicado en 2015

Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.

artículo científico publicado en 2015

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.

artículo científico publicado en 2013

Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

artículo científico publicado en 2015

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study

artículo científico publicado en 2013

Sequential expression of Trks A, B, and C in the regenerating olfactory neuroepithelium

scientific journal article

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.

artículo científico publicado en 2016

The effect of neonatal exposure to diethylstilbestrol, coumestrol, and beta-sitosterol on pituitary responsiveness and sexually dimorphic nucleus volume in the castrated adult rat

artículo científico publicado en 1995

The growing burden of diabetes mellitus in the US elderly population.

artículo científico publicado en 2008

Therapy of type 2 diabetes, cardiovascular death, and the UGDP

scientific article published on 01 November 1999

Treatment of type 2 diabetes mellitus

artículo científico publicado en 1998

Updated risk factors should be used to predict development of diabetes.

artículo científico publicado en 2017

Lista de obras de

10-year follow-up of intensive glucose control in type 2 diabetes

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.

Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes.

Algorithm: management of diabetes mellitus.

Algorithm: management of diabetes mellitus: dietary and drug therapy.

Basal insulin therapy in type 2 diabetes.

Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study

Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance

Emerging care for type 2 diabetes: using insulin to reach lower glycemic goals.

Evaluation of a self-administered oral glucose tolerance test

Impact of FDA guidance for developing diabetes drugs on trial design: from policy to practice.

Improper insulin administration may explain poor diabetes control

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research tri

Insulin analogues: new therapies for type 2 diabetes mellitus.

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients.

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease.

Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.

Oral agent therapy in the treatment of type 2 diabetes.

Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus

Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial

Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.

Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.

Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study

Sequential expression of Trks A, B, and C in the regenerating olfactory neuroepithelium

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.

The effect of neonatal exposure to diethylstilbestrol, coumestrol, and beta-sitosterol on pituitary responsiveness and sexually dimorphic nucleus volume in the castrated adult rat

The growing burden of diabetes mellitus in the US elderly population.

Therapy of type 2 diabetes, cardiovascular death, and the UGDP

Treatment of type 2 diabetes mellitus

Updated risk factors should be used to predict development of diabetes.